Drugs / TC-5619-238
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01472991 | Nov 2011 → Jul 2012 | attention deficit-hyperactivity disorder | Targacept Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TC-5619-238 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01472991 ↗ |